Private Client Services LLC Makes New $298,000 Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Posted by Anthony Miller on Apr 16th, 2024

Private Client Services LLC acquired a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,667 shares of the company’s stock, valued at approximately $298,000. Private Client Services LLC owned about 0.07% of VanEck Pharmaceutical ETF as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Allworth Financial LP bought a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $28,000. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $34,000. JPMorgan Chase & Co. purchased a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $46,000. Comerica Bank purchased a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth approximately $59,000. Finally, Cary Street Partners Investment Advisory LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth approximately $60,000.

VanEck Pharmaceutical ETF Stock Down 0.0 %

Shares of PPH stock opened at $85.44 on Tuesday. The company has a 50 day moving average of $88.96 and a 200-day moving average of $83.31. VanEck Pharmaceutical ETF has a 12-month low of $74.05 and a 12-month high of $91.16. The firm has a market cap of $516.06 million, a P/E ratio of 16.59 and a beta of 0.72.

VanEck Pharmaceutical ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.5328 per share. The ex-dividend date was Monday, April 1st.

VanEck Pharmaceutical ETF Company Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.